Niagen Bioscience share price logo

Niagen Bioscience

NASDAQ: NAGE

$2.69

+0.01

(+0.37%)

as on

Niagen Bioscience Stock Performance

as on October 7, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $2.66
    $2.71
    downward going graph

    1.12%

    Downside

    0.74%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $2.61
    $7.95
    downward going graph

    2.97%

    Downside

    195.54%

    Upside

    downward going graph

Niagen Bioscience share price movements today

Previous Close
$2.68
Open
$2.67
Volume
488.0K
Market Cap
$213.4M
Day's Low - High
$2.66 - $2.71
52 Week Low - High
$2.61 - $7.95

Niagen Bioscience Historical Returns

1 Month Return
-15.14 %
3 Month Return
-22.03 %
1 Year Return
-62.53 %
3 Year Return
0 %
5 Year Return
0 %

Niagen Bioscience Stock Fundamentals & Key Indicators

Check Niagen Bioscience market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$213.4M

EPS (TTM)

0.1942

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.75%

PE Ratio (TTM)

13.8

Industry PE ratio

-3.05

PEG Ratio

-0.79

EBITDA

18.5M

Revenue (TTM)

129.1M

Profit Margin

64.24%

Return On Equity TTM

20.50%

Niagen Bioscience vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Niagen Bioscience with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Niagen Bioscience image
Niagen Bioscience
Buy$213.4MNA13.8064.24%0.00%
Associated British Foods image
Associated British Foods
NA$16.9BNA13.527.53%3.48%
Kraft Heinz image
Kraft Heinz
Neutral$26.3B-40.59%-7.6432.82%7.33%
General Mills image
General Mills
Neutral$17.1B-47.52%-19.2033.43%7.70%

Stock Returns calculator for Niagen Bioscience Stock including INR - Dollar returns

The Niagen Bioscience stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Niagen Bioscience investment value today

Current value as on today

₹40,858

Returns

-₹59,142

(-59.14%)

Returns from Niagen Bioscience Stock

-₹62,535 (-62.53%)

Dollar Impact

₹3,393 (+3.39%)

Analyst Recommendation on Niagen Bioscience Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Niagen Bioscience. Average target price of $10.5

Niagen Bioscience Share Price Target

Get share price movements and forecasts by analysts on Niagen Bioscience.

Current Price

$2.69

Analyzed by

2 Analysts

High

$11

0

Low

$10

Niagen Bioscience target price $0, a slight upside of 0% compared to current price of $2.69. According to 2 analysts rating.

Indian Investors' Interest in Niagen Bioscience Stock

Search interest for Niagen Bioscience Stock has decreased by -50% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-50% versus previous 30 day period

Niagen Bioscience Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
22
22
25
29
30
31
33
33
31
29
Gross Profit
13
13
16
18
19
20
21
21
19
19
Operating Income
0
0
1
7
4
3
4
2
1
0
EBITDA
0
0
2
7
5
4
4
5
7
1
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
1
7
5
3
4
4
6
1
Income Tax Expense
-
-
-
0
0
0
0
0
0
0
Net Income
0
0
1
7
5
3
4
4
6
0
Net Profit Margin
60.74%
60.22%
63.49%
62.48%
63.42%
65.00%
64.52%
64.14%
63.47%
64.84%

Niagen Bioscience Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
21
31
46
59
67
72
83
99
129
Gross Profit
10
16
25
35
41
42
50
61
83
Operating Income
-16
-33
-31
-19
-27
-18
-5
7
14
EBITDA
-15
-32
-29
-18
-25
-14
-3
10
19
Interest Expense
0
0
0
0
0
-
-
-
-
Depreciation
0
0
1
1
1
1
1
1
1
Income Before Tax
-16
-33
-32
-19
-27
-16
-4
8
18
Income Tax Expense
-
-
-
-
-
-
-
0
0
Net Income
-11
-33
-32
-19
-27
-16
-4
8
17
Net Profit Margin
49.42%
50.88%
55.67%
59.53%
61.51%
59.40%
60.76%
61.84%
64.28%

Niagen Bioscience Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
0
0
1
7
5
3
4
4
6
0
Operating Cash Flow
0
0
3
8
7
1
3
0
-1
2
Investing Cash Flow
0
0
0
0
0
0
0
0
5
0
Financing Cash Flow
0
0
1
3
3
3
0
0
-2
-2
Change in Cash
0
0
4
12
10
4
3
0
1
0

Niagen Bioscience Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-11
-33
-32
-19
-27
-16
-4
8
17
Operating Cash Flow
-9
-20
-20
-10
-24
-15
7
12
13
Investing Cash Flow
4
-1
0
0
0
0
0
0
0
Financing Cash Flow
48
0
16
8
36
7
0
5
6
Change in Cash
43
-22
-3
-2
11
-7
6
17
20

Global Institutional Holdings in Niagen Bioscience

Check out the Institutions with significant holdings in Niagen Bioscience.

Funds
Holdings
Vanguard
3.95%
iShares
2.86%
VANGUARD INDEX FUNDS
2.66%
VANGUARD WORLD FUND
0.81%
Fidelity Salem Street Trust
0.72%
See all

Insights on Niagen Bioscience

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, NAGE has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Niagen Bioscience, Inc. Common Stock has experienced a drawdown of -62.5%, however The Kraft Heinz Company resisted the overall trend and outperformed by 49.2%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 6.31M → 963.0K (in $), with an average decrease of 84.8% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, NAGE stock has moved down by -7.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 33.98M → 29.78M (in $), with an average decrease of 4.3% per quarter

About Niagen Bioscience

Niagen Bioscience, Inc. operates as a bioscience company engages in developing healthy aging products. The company operates through Consumer products; Ingredients; and Pharmaceutical Segments. It provides finished dietary supplement products that contain its proprietary ingredients directly to consumers and distributors; nicotinamide adenine dinucleotide (NAD+), an essential coenzyme that regulates cellular metabolism; and develops and commercializes proprietary-based ingredient technologies, including food-grade, Niagen, and pharmaceutical-grade Niagen and supplies these ingredients as raw materials to the manufacturers of consumer products. In addition, it commercializes NAD+ precursor nicotinamide riboside as the flagship ingredient under NIAGEN brand name. The company distributes TRU NIAGEN products direct to consumers through its propriety e-commerce platform TRUNIAGEN.com, Amazon, and other internet marketplaces, as well as specialty retailers and authorized healthcare practitioners resellers. The company was formerly known as ChromaDex Corporation and changed its name to Niagen Bioscience, Inc. in March 2025. Niagen Bioscience, Inc. was founded in 1999 and is headquartered in Los Angeles, California.
OrganisationNiagen Bioscience
Headquarters10900 Wilshire Blvd, Suite 600, Los Angeles, CA, 90024, US
IndustryBiotechnology
CEORobert N. Fried

Key Management of Niagen Bioscience

Name

Title

Mr. Robert N. Fried

CEO & Director

Mr. Ozan Pamir C.F.A.

CFO & Principal Accounting Officer

Ms. Chu Yan

Managing Director of Asia Pacific

Kendall Knysch

Head of Media Relations & Partnerships

Wesley Yu

Vice President of Finance

Mr. Frank Louis Jaksch Jr.

Co-Founder & Chairman

Dr. Andrew Shao Ph.D.

Senior Vice President of Global Regulatory & Scientific Affairs

Ms. Michiko Kelley

Chief Marketing Officer

Mr. James Lee

Controller

Mr. Carlos Lopez

Senior VP & General Counsel

FAQs

What is Niagen Bioscience share price today?

Niagen Bioscience share price today is $2.69 as on at the close of the market. Niagen Bioscience share today touched a day high of $2.71 and a low of $2.66.

What is the 52 week high and 52 week low for Niagen Bioscience share?

Niagen Bioscience share touched a 52 week high of $7.95 on and a 52 week low of $2.61 on . Niagen Bioscience stock price today i.e. is closed at $2.69,which is 66.16% down from its 52 week high and 3.07% up from its 52 week low.

What is Niagen Bioscience's market capitalisation today?

Niagen Bioscience market capitalisation is $0.00T as on .

How to invest in Niagen Bioscience Stock (NAGE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Niagen Bioscience on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Niagen Bioscience Stock (NAGE) from India?

Indian investors can start investing in Niagen Bioscience (NAGE) shares with as little as ₹96.775001525879 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.75 in Niagen Bioscience stock (as per the Rupee-Dollar exchange rate as on ). Based on Niagen Bioscience share’s latest price of $2.69 as on October 7, 2026 at 8:46 am IST, you will get 3.7175 shares of Niagen Bioscience. Learn more about fractional shares .